These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31245879)

  • 1. Health-care resource use and current treatment of adult atopic dermatitis patients in Japan: A retrospective claims database analysis.
    Igarashi A; Fujita H; Arima K; Inoue T; Dorey J; Fukushima A; Taguchi Y
    J Dermatol; 2019 Aug; 46(8):652-661. PubMed ID: 31245879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases.
    Shrestha S; Miao R; Wang L; Chao J; Yuce H; Wei W
    Adv Ther; 2017 Aug; 34(8):1989-2006. PubMed ID: 28707285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Care Resource Utilization and Costs Among Adults with Atopic Dermatitis in the United States: A Claims-Based Analysis.
    Drucker AM; Qureshi AA; Amand C; Villeneuve S; Gadkari A; Chao J; Kuznik A; Bégo-Le-Bagousse G; Eckert L
    J Allergy Clin Immunol Pract; 2018; 6(4):1342-1348. PubMed ID: 29174063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of atopic manifestations in patients with atopic dermatitis--analysis of administrative claims.
    Suh DC; Sung J; Gause D; Raut M; Huang J; Choi IS
    J Manag Care Pharm; 2007; 13(9):778-89. PubMed ID: 18062729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden.
    Katoh N; Saeki H; Kataoka Y; Etoh T; Teramukai S; Takagi H; Tajima Y; Ardeleanu M; Rizova E; Arima K;
    J Dermatol; 2019 Apr; 46(4):290-300. PubMed ID: 30756423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of variations in access to care for children with atopic dermatitis.
    Siegfried EC; Paller AS; Mina-Osorio P; Vekeman F; Kaur M; Mallya UG; Héroux J; Miao R; Gadkari A
    BMC Dermatol; 2020 Dec; 20(1):24. PubMed ID: 33341118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing Patterns for Atopic Dermatitis in the United States.
    Pona A; Cline A; Kolli S; Feldman SF; Fleischer AFJ
    J Drugs Dermatol; 2019 Oct; 18(10):987-990. PubMed ID: 31584776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey.
    Eckert L; Gupta S; Amand C; Gadkari A; Mahajan P; Gelfand JM
    J Am Acad Dermatol; 2018 Jan; 78(1):54-61.e1. PubMed ID: 29017738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace.
    Alexander T; Maxim E; Cardwell LA; Chawla A; Feldman SR
    J Dermatolog Treat; 2018 May; 29(3):238-240. PubMed ID: 28789575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain.
    Artime E; Serra E; Mert C; Díaz-Cerezo S; Huete T; Hernández-Subirá I; Lledo-Bryant L; Sicras-Mainar A
    Actas Dermosifiliogr; 2023 Jan; 114(1):T9-T18. PubMed ID: 36368579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain.
    Artime E; Serra E; Mert C; Díaz-Cerezo S; Huete T; Hernández-Subirá I; Lledo-Bryant L; Sicras-Mainar A
    Actas Dermosifiliogr; 2023 Jan; 114(1):9-18. PubMed ID: 36030827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective cohort study evaluating healthcare resource utilization in patients with asthma in Japan.
    Inoue H; Kozawa M; Milligan KL; Funakubo M; Igarashi A; Loefroth E
    NPJ Prim Care Respir Med; 2019 Apr; 29(1):13. PubMed ID: 31036818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.
    Delea TE; Gokhale M; Makin C; Hussein MA; Vanderpoel J; Sandman T; Chang J; Sung J; Pinkston P; Gause D; Jackson M
    J Manag Care Pharm; 2007 May; 13(4):349-59. PubMed ID: 17506601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of cutaneous infections in children and adults with atopic dermatitis.
    Sandhu JK; Salame N; Ehsani-Chimeh N; Armstrong AW
    Pediatr Dermatol; 2019 May; 36(3):303-310. PubMed ID: 30968453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States.
    Jain R; Fu AC; Lim J; Wang C; Elder J; Sander SD; Tan H
    J Manag Care Spec Pharm; 2018 Jan; 24(1):73-82. PubMed ID: 29290177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US health care utilization and costs in adult patients with atopic dermatitis by disease severity.
    Wang X; Boytsov NN; Gorritz M; Malatestinic WN; Goldblum OM; Wade RL
    J Manag Care Spec Pharm; 2022 Jan; 28(1):69-77. PubMed ID: 34949118
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermatologists and allergists have far more experience and use more complex treatment regimens in the treatment of atopic dermatitis than other physicians.
    Henderson RL; Fleischer AB; Feldman SR
    J Cutan Med Surg; 2001; 5(3):211-6. PubMed ID: 11685667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data.
    Choong CK; Ford JH; Nyhuis AW; Robinson RL; Aurora SK
    J Manag Care Spec Pharm; 2018 Sep; 24(9):921-928. PubMed ID: 30156448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective.
    Fenske DC; Ding Y; Morrow P; Smith SG; Silver MK; Moynihan M; Manjelievskaia J
    J Manag Care Spec Pharm; 2023 Apr; 29(4):409-419. PubMed ID: 36989453
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy.
    Gori N; Chiricozzi A; Malvaso D; D'Urso DF; Caldarola G; De Simone C; Peris K
    Dermatology; 2021; 237(4):535-541. PubMed ID: 33477153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.